Skip to content

Effectiveness of Rotavirus Immunization in Nicaragua

Effectiveness of Rotavirus Immunization at the Community Level in Nicaragua

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01133808
Enrollment
667
Registered
2010-05-31
Start date
2010-01-31
Completion date
2011-01-31
Last updated
2011-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea

Keywords

diarrhea, childhood, rotavirus, vaccine, Nicaragua

Brief summary

The purpose of the investigators study is to compare the rates of childhood diarrhea at the community level before and after the rotavirus vaccination program in León, Nicaragua. From preliminary studies, the investigators anticipate about a 28% reduction in diarrhea following the vaccination program among children who received the vaccine, and a smaller reduction in diarrhea among children who did not receive the vaccine, due to the effects of herd immunity. In addition, the investigators will collect stool samples from children who develop diarrhea in order determine the etiology of childhood diarrhea in the post-rotavirus immunization era.

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Thrasher Research Fund
CollaboratorOTHER
Fogarty International Center of the National Institute of Health
CollaboratorNIH
Sylvia Becker-Dreps
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 5 Years
Healthy volunteers
No

Inclusion criteria

* Age under 5 years, inclusion in health and demographic surveillance system (CIDS) in Leon, Nicaragua

Exclusion criteria

* Parents do not consent to child's participation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026